Trispan · DIN 02470632 · 20 mg/mL · 1mL-Amp Pk
Limited Use, Reason for Use code 580 required; Health Canada lists this DIN as Cancelled post market since 2024-03-11 — choose a marketed DIN from the same-category list.Discontinued March 11, 2024 · checked October 5, 2026
StatusLimited Use, Reason for Use code 580 required; Health Canada lists this DIN as Cancelled post market since 2024-03-11 — choose a marketed DIN from the same-category list.
Write on scriptReason for Use code 580 (criteria below); Health Canada lists this DIN as Cancelled post market since 2024-03-11 — choose a marketed DIN from the same-category list.
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 580
Reason for Use code 580
For intra-articular, intrasynovial, or periarticular use in adults and adolescents for the symptomatic treatment of subacute and chronic inflammatory joint diseases including:
- Rheumatoid arthritis
- Juvenile Idiopathic Arthritis (JIA)*
- Osteoarthritis and post-traumatic arthritis
- Synovitis, tendinitis, bursitis and epicondylitis
*Note: triamcinolone hexacetonide injectable suspension may also be used as an intra-articular injection in children aged 3-12 years with Juvenile Idiopathic Arthritis.
Coverage limit:
LU Authorization Period: Indefinite
No interchangeable product listed in the Ontario extract
Trispan · DIN 02470632
Manufacturer: Medexus Inc.; listing date 2020-06-30
Health Canada: Cancelled post market since 2024-03-11 · brand TRISPAN · ATC H02AB08 TRIAMCINOLONE · form Suspension · route Periarticular, Intra-articular, Intrasynovial · ingredients TRIAMCINOLONE HEXACETONIDE 20 MG/ML · company Medexus pharmaceuticals inc. · schedule Prescription
Trispan: Formulary list price $18.00 per unit (the source does not state the unit; exact figure $18.0000). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02470632)
Source record
DIN 02470632: Trispan
Raw flags: sec12=Y, sec3=Y
Item: 680400114; group id 721; item number 1781; lccId 00335; manufacturer id MDX
Source form: 1mL-Amp Pk; strength: 20mg/mL
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $18.0000; ministry $18.0000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02470632
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=95963
Shortage status: resolved shortage (ended March 11, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02470632
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since March 11, 2024 — choose a marketed DIN from the same-category list.